BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE was reported 24312 times

BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOOTH EROSION 382 0.3118
1 DRUG DETOXIFICATION 266 0.2975
2 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 137 0.2542
3 THERAPY NAIVE 20 0.1613
4 INTENTIONAL UNDERDOSE 1028 0.1406
5 SELECTIVE ABORTION 24 0.1371
6 CHILD NEGLECT 31 0.1286
7 SUBSTANCE ABUSE 1014 0.1244
8 ORAL ADMINISTRATION COMPLICATION 108 0.1161
9 DRUG SCREEN NEGATIVE 178 0.1011
10 PRODUCT DOSAGE FORM ISSUE 44 0.0911
11 TREMOR NEONATAL 37 0.0830
12 DIARRHOEA NEONATAL 10 0.0787
13 VISION ABNORMAL NEONATAL 30 0.0718
14 DENTAL CARIES 753 0.0680
15 DRUG WITHDRAWAL SYNDROME NEONATAL 920 0.0621
16 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 9 0.0559
17 NEONATAL HYPOACUSIS 13 0.0544
18 CRIME 14 0.0530
19 WEIGHT DECREASE NEONATAL 10 0.0515
20 DETOXIFICATION 17 0.0491
21 LEARNING DISABILITY 259 0.0486
22 ALCOHOL ABUSE 124 0.0463
23 JAUNDICE NEONATAL 80 0.0422
24 THEFT 27 0.0406
25 DRUG DIVERSION 242 0.0391
26 DRUG WITHDRAWAL SYNDROME 3371 0.0384
27 EXPOSURE DURING BREAST FEEDING 125 0.0377
28 PRODUCT PREPARATION ERROR 774 0.0376
29 TONGUE BLISTERING 83 0.0372
30 PULPITIS DENTAL 35 0.0371
31 VICTIM OF ABUSE 9 0.0332
32 EXPOSURE VIA BODY FLUID 26 0.0331
33 TOOTH DEPOSIT 11 0.0317
34 EXPOSURE TO ALLERGEN 10 0.0313
35 PILOERECTION 34 0.0311
36 DEVELOPMENTAL DELAY 280 0.0310
37 PERIODONTITIS 65 0.0300
38 EUPHORIC MOOD 305 0.0297
39 HYPERAESTHESIA TEETH 34 0.0269
40 TOOTH FRACTURE 297 0.0269
41 DRUG DEPENDENCE 4326 0.0269
42 TEETH BRITTLE 28 0.0267
43 VICTIM OF SEXUAL ABUSE 14 0.0266
44 SUDDEN INFANT DEATH SYNDROME 13 0.0264
45 DENTAL RESTORATION FAILURE 19 0.0264
46 EXPOSURE VIA FATHER 33 0.0253
47 IMPRISONMENT 43 0.0243
48 SELECTIVE EATING DISORDER 22 0.0242
49 EXPOSURE VIA BREAST MILK 93 0.0233
50 YAWNING 62 0.0232
51 ANKYLOGLOSSIA CONGENITAL 9 0.0224
52 LEGAL PROBLEM 16 0.0217
53 FEELING OF BODY TEMPERATURE CHANGE 126 0.0215
54 DRUG SCREEN POSITIVE 169 0.0214
55 VICTIM OF CRIME 26 0.0210
56 DRUG TOLERANCE INCREASED 16 0.0205
57 TOOTH IMPACTED 9 0.0194
58 SUBSTANCE DEPENDENCE 13 0.0193
59 WRONG TECHNIQUE IN DRUG USAGE PROCESS 662 0.0182
60 DRUG LEVEL FLUCTUATING 16 0.0180
61 TOOTH LOSS 359 0.0173
62 MICROCEPHALY 22 0.0171
63 AGORAPHOBIA 23 0.0168
64 SOCIAL ANXIETY DISORDER 11 0.0167
65 SKULL FRACTURE 27 0.0166
66 PERIODONTAL DISEASE 23 0.0164
67 GINGIVAL RECESSION 31 0.0161
68 POST-TRAUMATIC STRESS DISORDER 108 0.0161
69 TOOTHACHE 288 0.0159
70 DISABILITY 312 0.0158
71 SUBSTANCE USE DISORDER 50 0.0157
72 PREMATURE SEPARATION OF PLACENTA 24 0.0156
73 BORDERLINE PERSONALITY DISORDER 11 0.0155
74 DENTAL DISCOMFORT 13 0.0155
75 PLACENTA PRAEVIA 12 0.0153
76 HEPATITIS C 180 0.0149
77 GLOSSITIS 52 0.0146
78 TONGUE ULCERATION 49 0.0145
79 DRUG ABUSE 1132 0.0136
80 AGITATION NEONATAL 13 0.0136
81 PERSONAL RELATIONSHIP ISSUE 9 0.0135
82 LIMB CRUSHING INJURY 10 0.0133
83 CYTOKINE STORM 9 0.0131
84 FOETAL EXPOSURE DURING PREGNANCY 1064 0.0131
85 ANTISOCIAL BEHAVIOUR 13 0.0130
86 ALCOHOL WITHDRAWAL SYNDROME 11 0.0126
87 TOOTH DISCOLOURATION 37 0.0126
88 NON-ALCOHOLIC STEATOHEPATITIS 13 0.0125
89 EMOTIONAL DISTRESS 1485 0.0123
90 SUPPRESSED LACTATION 9 0.0120
91 NONINFECTIVE GINGIVITIS 17 0.0117
92 ACCIDENTAL DRUG INTAKE BY CHILD 18 0.0117
93 NEONATAL RESPIRATORY DISTRESS 11 0.0117
94 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 78 0.0115
95 THERAPEUTIC PRODUCT INEFFECTIVE 44 0.0114
96 NEONATAL DISORDER 18 0.0114
97 PRE-EXISTING CONDITION IMPROVED 70 0.0112
98 SELF ESTEEM DECREASED 27 0.0111
99 ACCIDENTAL EXPOSURE 46 0.0110
100 TONGUE INJURY 10 0.0107
101 TOOTH DISORDER 235 0.0106
102 LOW BIRTH WEIGHT BABY 80 0.0101
103 GUN SHOT WOUND 19 0.0100
104 FORMICATION 69 0.0099
105 MENTAL DISORDER 428 0.0098
106 HOMICIDE 18 0.0098
107 DRUG SCREEN FALSE POSITIVE 27 0.0097
108 JUDGEMENT IMPAIRED 14 0.0096
109 ROAD TRAFFIC ACCIDENT 401 0.0096
110 WITHDRAWAL SYNDROME 402 0.0096
111 FEEDING DISORDER NEONATAL 10 0.0096
112 TOOTH INJURY 40 0.0092
113 IMPAIRED DRIVING ABILITY 104 0.0091
114 TONGUE DISCOMFORT 38 0.0089
115 DRUG TOLERANCE 45 0.0089
116 DRUG EXPOSURE DURING PREGNANCY 302 0.0089
117 GINGIVAL SWELLING 39 0.0088
118 ENERGY INCREASED 52 0.0088
119 LOGORRHOEA 31 0.0088
120 OVERDOSE 1871 0.0087
121 ORAL DISORDER 63 0.0086
122 MATERNAL EXPOSURE DURING PREGNANCY 748 0.0084
123 SUBSTANCE USE 13 0.0083
124 NECK INJURY 24 0.0082
125 GENERALISED ANXIETY DISORDER 12 0.0082
126 TACHYPHRENIA 28 0.0081
127 SOMNAMBULISM 53 0.0081
128 GENERAL PHYSICAL CONDITION ABNORMAL 54 0.0080
129 PSYCHOMOTOR HYPERACTIVITY 132 0.0079
130 BLOOD TESTOSTERONE DECREASED 54 0.0079
131 JAW FRACTURE 17 0.0079
132 TOOTH ABSCESS 80 0.0078
133 DRUG USE DISORDER 66 0.0078
134 PREMATURE LABOUR 44 0.0078
135 ORAL MUCOSAL ERYTHEMA 12 0.0077
136 PRESCRIBED OVERDOSE 149 0.0077
137 MULTIPLE CONGENITAL ABNORMALITIES 11 0.0076
138 MATERNAL DRUGS AFFECTING FOETUS 58 0.0076
139 SENSITIVITY OF TEETH 13 0.0075
140 SMALL FOR DATES BABY 37 0.0074
141 NARCOLEPSY 14 0.0074
142 MAJOR DEPRESSION 54 0.0074
143 ATTENTION DEFICIT HYPERACTIVITY DISORDER 31 0.0074
144 RESPIRATORY RATE DECREASED 23 0.0073
145 BIPOLAR DISORDER 79 0.0073
146 FOETAL DISTRESS SYNDROME 15 0.0071
147 APPENDIX DISORDER 10 0.0071
148 ALCOHOLISM 30 0.0070
149 PREMATURE DELIVERY 111 0.0070
150 PRE-ECLAMPSIA 33 0.0069
151 HOMICIDAL IDEATION 28 0.0069
152 BACK INJURY 75 0.0069
153 SUICIDAL IDEATION 629 0.0069
154 UTERINE DISORDER 16 0.0069
155 EMOTIONAL POVERTY 12 0.0068
156 BIPOLAR I DISORDER 15 0.0068
157 FEELING GUILTY 9 0.0068
158 RESPIRATORY DISORDER NEONATAL 11 0.0068
159 TOBACCO USER 10 0.0067
160 PHYSICAL ASSAULT 14 0.0067
161 THERAPEUTIC RESPONSE UNEXPECTED 300 0.0067
162 TONGUE DISORDER 48 0.0066
163 TONGUE DISCOLOURATION 29 0.0066
164 ORAL MUCOSAL EXFOLIATION 10 0.0066
165 MIOSIS 53 0.0066
166 COLD SWEAT 115 0.0065
167 LOOSE TOOTH 21 0.0065
168 ALCOHOL USE 24 0.0065
169 GINGIVITIS 35 0.0065
170 PULMONARY FUNCTION TEST ABNORMAL 10 0.0064
171 ENDOCARDITIS 32 0.0062
172 PARANOIA 107 0.0062
173 CONGENITAL ANOMALY 48 0.0062
174 INTENTIONAL DRUG MISUSE 129 0.0062
175 PRODUCT SOLUBILITY ABNORMAL 31 0.0061
176 PREMATURE BABY 184 0.0061
177 CONVULSION 349 0.0061
178 ABORTION SPONTANEOUS 244 0.0061
179 KNEE DEFORMITY 9 0.0061
180 ABNORMAL SLEEP-RELATED EVENT 8 0.0061
181 AXILLARY PAIN 9 0.0060
182 SOCIAL AVOIDANT BEHAVIOUR 35 0.0060
183 RESTLESS LEGS SYNDROME 109 0.0060
184 TOOTH INFECTION 79 0.0060
185 CRANIOCEREBRAL INJURY 18 0.0059
186 MOUTH INJURY 9 0.0059
187 ENDODONTIC PROCEDURE 15 0.0059
188 SLEEP TALKING 10 0.0059
189 INTENTIONAL PRODUCT MISUSE 515 0.0059
190 URINARY HESITATION 14 0.0059
191 ORAL MUCOSAL ERUPTION 9 0.0059
192 FEELING OF DESPAIR 27 0.0058
193 ABORTION INDUCED 54 0.0057
194 GINGIVAL DISORDER 22 0.0057
195 PANIC DISORDER 22 0.0057
196 GLOSSODYNIA 126 0.0056
197 BREAKTHROUGH PAIN 13 0.0056
198 HYPERHIDROSIS 722 0.0056
199 EXCORIATION 14 0.0055
200 PANIC ATTACK 199 0.0055
201 HALLUCINATION, AUDITORY 85 0.0053
202 ORAL DISCOMFORT 74 0.0053
203 LOSS OF EMPLOYMENT 16 0.0053
204 FACIAL BONES FRACTURE 19 0.0053
205 PRODUCT USE ISSUE 984 0.0052
206 INJECTION SITE ABSCESS 13 0.0052
207 LIGAMENT RUPTURE 23 0.0052
208 APHTHOUS STOMATITIS 12 0.0052
209 BRUXISM 28 0.0052
210 BRAIN INJURY 52 0.0052
211 CONCUSSION 40 0.0052
212 ABORTION 15 0.0051
213 APATHY 75 0.0051
214 ORAL PAIN 114 0.0051
215 DEPENDENCE 275 0.0050
216 INCOHERENT 32 0.0049
217 SLOW SPEECH 12 0.0049
218 INJECTION SITE NECROSIS 10 0.0049
219 MASTICATION DISORDER 15 0.0049
220 PSYCHOTIC SYMPTOM 10 0.0048
221 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 873 0.0048
222 VOMITING PROJECTILE 14 0.0048
223 ANXIETY 1371 0.0048
224 READING DISORDER 11 0.0048
225 BILIARY COLIC 14 0.0048
226 SUICIDAL BEHAVIOUR 20 0.0048
227 SACROILIITIS 9 0.0048
228 HALLUCINATIONS, MIXED 20 0.0048
229 RESPIRATORY DEPRESSION 58 0.0047
230 RESTLESSNESS 171 0.0047
231 CLEFT PALATE 9 0.0047
232 THERAPY CESSATION 239 0.0047
233 HYPOPNOEA 16 0.0046
234 DEPRESSION 1043 0.0046
235 SELF-INJURIOUS IDEATION 19 0.0045
236 ACCIDENT AT WORK 10 0.0045
237 ANIMAL BITE 12 0.0045
238 ANXIETY DISORDER 15 0.0045
239 PHARYNGEAL OEDEMA 68 0.0044
240 DRUG PRESCRIBING ERROR 84 0.0044
241 HYPOAESTHESIA ORAL 65 0.0043
242 IMPAIRED WORK ABILITY 92 0.0043
243 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 862 0.0042
244 MENTAL IMPAIRMENT 103 0.0042
245 FEELING ABNORMAL 1017 0.0042
246 NEAR DEATH EXPERIENCE 14 0.0042
247 NEONATAL RESPIRATORY DISTRESS SYNDROME 15 0.0042
248 HALLUCINATION 319 0.0042
249 PAIN 2574 0.0042
250 FOOD CRAVING 22 0.0042
251 SEROTONIN SYNDROME 80 0.0042
252 SWOLLEN TONGUE 130 0.0042
253 PREMATURE RUPTURE OF MEMBRANES 10 0.0041
254 ANGER 139 0.0041
255 PRODUCT FORMULATION ISSUE 27 0.0041
256 INSOMNIA 1089 0.0041
257 THERMAL BURN 29 0.0041
258 RETROPERITONEAL HAEMATOMA 9 0.0041
259 DISSOCIATION 31 0.0040
260 LIP BLISTER 11 0.0040
261 SPINAL COLUMN INJURY 9 0.0040
262 ALLERGIC REACTION TO EXCIPIENT 8 0.0040
263 ABSCESS LIMB 17 0.0040
264 DRUG EFFECT LESS THAN EXPECTED 59 0.0040
265 HEPATIC PAIN 17 0.0040
266 INTERVERTEBRAL DISC DISORDER 17 0.0040
267 IRRITABILITY 239 0.0040
268 QUALITY OF LIFE DECREASED 53 0.0039
269 MATERNAL EXPOSURE DURING BREAST FEEDING 16 0.0039
270 AFFECTIVE DISORDER 31 0.0039
271 LUMBAR VERTEBRAL FRACTURE 18 0.0039
272 STOMATITIS 238 0.0039
273 BACK DISORDER 63 0.0039
274 SPEECH DISORDER DEVELOPMENTAL 11 0.0038
275 INTENTIONAL PRODUCT USE ISSUE 335 0.0038
276 PANCREATITIS CHRONIC 9 0.0038
277 FOETAL GROWTH RESTRICTION 23 0.0038
278 DECREASED INTEREST 22 0.0037
279 FEELING COLD 103 0.0037
280 HANGOVER 13 0.0037
281 RIB FRACTURE 76 0.0037
282 PSYCHOTIC DISORDER 109 0.0037
283 HORMONE LEVEL ABNORMAL 18 0.0037
284 URINE ANALYSIS ABNORMAL 11 0.0037
285 OEDEMA MOUTH 12 0.0037
286 INJECTION SITE INFECTION 12 0.0036
287 FEELING DRUNK 27 0.0036
288 OBSESSIVE-COMPULSIVE DISORDER 29 0.0036
289 RETCHING 77 0.0036
290 MUSCLE TWITCHING 83 0.0036
291 OLIGOHYDRAMNIOS 12 0.0036
292 UNEVALUABLE EVENT 268 0.0035
293 THINKING ABNORMAL 66 0.0035
294 TALIPES 11 0.0035
295 APPENDICITIS PERFORATED 9 0.0035
296 STILLBIRTH 17 0.0035
297 ABDOMINAL HERNIA 16 0.0035
298 CRYING 126 0.0035
299 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
300 INTERVERTEBRAL DISC PROTRUSION 75 0.0034
301 INTERVERTEBRAL DISC DEGENERATION 31 0.0033
302 SNEEZING 75 0.0033
303 BEHAVIOUR DISORDER 18 0.0033
304 ORAL INFECTION 13 0.0033
305 MOUTH SWELLING 19 0.0033
306 DRUG LEVEL ABOVE THERAPEUTIC 15 0.0033
307 GINGIVAL PAIN 26 0.0033
308 ACCIDENT 39 0.0033
309 ARTHRITIS INFECTIVE 15 0.0032
310 ACTIVITIES OF DAILY LIVING IMPAIRED 64 0.0032
311 FLUID INTAKE REDUCED 16 0.0032
312 CERVICAL VERTEBRAL FRACTURE 11 0.0032
313 FORCED EXPIRATORY VOLUME DECREASED 9 0.0032
314 SKIN ABRASION 15 0.0032
315 HALLUCINATION, VISUAL 67 0.0032
316 SUICIDE ATTEMPT 192 0.0032
317 THERAPY CHANGE 31 0.0031
318 PROCEDURAL PAIN 87 0.0031
319 CLAVICLE FRACTURE 12 0.0031
320 IMPAIRED QUALITY OF LIFE 45 0.0031
321 CEREBRAL DISORDER 23 0.0031
322 SALIVARY HYPERSECRETION 31 0.0031
323 SLEEP APNOEA SYNDROME 59 0.0031
324 LOSS OF CONSCIOUSNESS 395 0.0031
325 SEXUAL DYSFUNCTION 36 0.0031
326 DRUG LEVEL DECREASED 31 0.0030
327 PERSONALITY CHANGE 28 0.0030
328 UNRESPONSIVE TO STIMULI 77 0.0030
329 POTENTIATING DRUG INTERACTION 10 0.0030
330 FEAR 80 0.0030
331 ENURESIS 12 0.0030
332 VITAMIN B12 DEFICIENCY 12 0.0030
333 SPINAL DISORDER 28 0.0030
334 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 162 0.0029
335 JOINT INJURY 63 0.0029
336 INADEQUATE ANALGESIA 25 0.0029
337 ENDOMETRIOSIS 14 0.0029
338 AMNESIA 191 0.0029
339 TREMOR 486 0.0029
340 DISTURBANCE IN ATTENTION 157 0.0029
341 PANIC REACTION 21 0.0029
342 PRIAPISM 10 0.0029
343 IRON DEFICIENCY 13 0.0029
344 MALABSORPTION 15 0.0029
345 VOMITING 1350 0.0029
346 EXPOSURE DURING PREGNANCY 178 0.0029
347 GALLBLADDER DISORDER 51 0.0029
348 MOOD SWINGS 91 0.0029
349 SLEEP TERROR 12 0.0028
350 MUSCLE CONTRACTIONS INVOLUNTARY 10 0.0028
351 ADVERSE EVENT 262 0.0028
352 INJURY 199 0.0028
353 MIGRAINE 270 0.0028
354 HAND FRACTURE 20 0.0028
355 CARPAL TUNNEL SYNDROME 39 0.0028
356 PSYCHOLOGICAL TRAUMA 24 0.0028
357 NERVOUSNESS 145 0.0028
358 LIMB INJURY 75 0.0028
359 FAECALOMA 15 0.0027
360 DYSPHEMIA 12 0.0027
361 ROTATOR CUFF SYNDROME 35 0.0027
362 PHYSICAL DISABILITY 12 0.0027
363 SOMNOLENCE 546 0.0027
364 SPINAL FUSION SURGERY 11 0.0027
365 PSYCHIATRIC SYMPTOM 20 0.0027
366 ECONOMIC PROBLEM 41 0.0027
367 TOXICITY TO VARIOUS AGENTS 456 0.0027
368 PREGNANCY 54 0.0027
369 HEAD INJURY 85 0.0027
370 PLANTAR FASCIITIS 9 0.0027
371 FEELING JITTERY 51 0.0027
372 AGITATION 195 0.0027
373 ACCIDENTAL OVERDOSE 97 0.0026
374 TOOTH EXTRACTION 33 0.0026
375 ANKLE FRACTURE 41 0.0026
376 JOINT DISLOCATION 28 0.0026
377 DYSURIA 97 0.0026
378 FACE INJURY 10 0.0026
379 MOUTH ULCERATION 55 0.0026
380 NERVE INJURY 29 0.0026
381 NIGHTMARE 90 0.0026
382 HYPERREFLEXIA 9 0.0026
383 APHTHOUS ULCER 20 0.0026
384 LETHARGY 148 0.0026
385 UPPER LIMB FRACTURE 51 0.0026
386 FOOT FRACTURE 48 0.0025
387 SEDATION 66 0.0025
388 SCREAMING 16 0.0025
389 WRIST FRACTURE 30 0.0025
390 APPARENT DEATH 9 0.0025
391 ABNORMAL BEHAVIOUR 99 0.0025
392 ERECTILE DYSFUNCTION 64 0.0025
393 NERVE COMPRESSION 23 0.0025
394 EMOTIONAL DISORDER 76 0.0025
395 LOSS OF LIBIDO 22 0.0024
396 LACERATION 23 0.0024
397 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 15 0.0024
398 MENTAL STATUS CHANGES 67 0.0024
399 OFF LABEL USE 2109 0.0024
400 OVARIAN CYST 24 0.0024
401 DELUSION 37 0.0024
402 SNORING 9 0.0024
403 SEIZURE 275 0.0024
404 OEDEMA PERIPHERAL 290 0.0024
405 HYPERSOMNIA 68 0.0024
406 DYSPHORIA 12 0.0024
407 UNDERDOSE 173 0.0024
408 LOWER LIMB FRACTURE 45 0.0023
409 OESOPHAGEAL DISORDER 9 0.0023
410 SCIATICA 37 0.0023
411 DYSARTHRIA 87 0.0023
412 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 111 0.0023
413 CERVIX CARCINOMA 9 0.0023
414 FIBROMYALGIA 56 0.0023
415 PROSTATOMEGALY 9 0.0023
416 PRODUCT SUBSTITUTION ISSUE 131 0.0023
417 MYDRIASIS 29 0.0023
418 SCOLIOSIS 14 0.0023
419 SLUGGISHNESS 23 0.0023
420 URINARY RETENTION 75 0.0022
421 ABNORMAL DREAMS 62 0.0022
422 APPENDICECTOMY 8 0.0022
423 HICCUPS 18 0.0022
424 SELF-MEDICATION 9 0.0022
425 LEG AMPUTATION 9 0.0022
426 PRODUCT TASTE ABNORMAL 29 0.0021
427 SCHIZOPHRENIA 26 0.0021
428 TIBIA FRACTURE 10 0.0021
429 TRISMUS 11 0.0021
430 CONSTIPATION 463 0.0021
431 SKIN LACERATION 23 0.0021
432 MENISCUS INJURY 13 0.0021
433 NAUSEA 1664 0.0021
434 GESTATIONAL DIABETES 10 0.0021
435 HYPERTHERMIA 16 0.0021
436 SUBCUTANEOUS ABSCESS 10 0.0021
437 BREAST MASS 14 0.0021
438 OCULAR ICTERUS 9 0.0021
439 HYPERVENTILATION 12 0.0021
440 CAESAREAN SECTION 24 0.0021
441 FOOD POISONING 11 0.0021
442 AUTOIMMUNE DISORDER 20 0.0020
443 CHILLS 240 0.0020
444 PHARYNGEAL SWELLING 20 0.0020
445 POOR QUALITY SLEEP 44 0.0020
446 RENAL TUBULAR NECROSIS 20 0.0020
447 DROOLING 14 0.0020
448 MOOD ALTERED 55 0.0020
449 ULCER 32 0.0020
450 DRY MOUTH 161 0.0020
451 AGGRESSION 99 0.0020
452 AFFECT LABILITY 19 0.0020
453 INGUINAL HERNIA 12 0.0020
454 MANIA 32 0.0019
455 LACRIMATION INCREASED 58 0.0019
456 MUSCULOSKELETAL DISCOMFORT 33 0.0019
457 SKIN TIGHTNESS 9 0.0019
458 WEIGHT FLUCTUATION 20 0.0019
459 BACK PAIN 444 0.0019
460 DECREASED APPETITE 443 0.0019
461 ARTHROPOD BITE 14 0.0019
462 RENAL PAIN 20 0.0019
463 KIDNEY INFECTION 37 0.0019
464 EATING DISORDER 40 0.0019
465 FAECAL INCONTINENCE 9 0.0019
466 APHAGIA 9 0.0019
467 HERNIA 36 0.0019
468 RHINORRHOEA 120 0.0019
469 FRUSTRATION TOLERANCE DECREASED 15 0.0019
470 SPEECH DISORDER 97 0.0018
471 APPLICATION SITE VESICLES 12 0.0018
472 THROAT TIGHTNESS 50 0.0018
473 GRAND MAL CONVULSION 17 0.0018
474 ARTHROPATHY 102 0.0018
475 DEPRESSED MOOD 97 0.0018
476 HEPATOMEGALY 18 0.0018
477 BRAIN OEDEMA 23 0.0018
478 DYSKINESIA 74 0.0018
479 APPETITE DISORDER 12 0.0018
480 ANEURYSM 9 0.0018
481 HOSPITALISATION 277 0.0018
482 HEADACHE 1129 0.0018
483 NICOTINE DEPENDENCE 14 0.0018
484 DELIRIUM 62 0.0018
485 EMPHYSEMA 18 0.0018
486 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
487 CONTRAINDICATED PRODUCT ADMINISTERED 54 0.0018
488 CELLULITIS 88 0.0017
489 NEPHROLITHIASIS 80 0.0017
490 PARKINSONISM 17 0.0017
491 MUSCLE ATROPHY 22 0.0017
492 BONE LOSS 26 0.0017
493 NECK PAIN 96 0.0017
494 DISORIENTATION 68 0.0017
495 FLANK PAIN 16 0.0017
496 LOCALISED INFECTION 41 0.0017
497 POISONING 21 0.0017
498 MALAISE 733 0.0017
499 STAPHYLOCOCCAL INFECTION 55 0.0017
500 RESPIRATORY DISTRESS 46 0.0017
501 GASTROENTERITIS VIRAL 30 0.0017
502 CYANOSIS 26 0.0017
503 NEURALGIA 40 0.0016
504 RENAL CYST 13 0.0016
505 MOUTH HAEMORRHAGE 12 0.0016
506 SCAR 28 0.0016
507 DRUG LEVEL BELOW THERAPEUTIC 9 0.0016
508 FEEDING DISORDER 33 0.0016
509 SMALL INTESTINAL OBSTRUCTION 20 0.0016
510 MUSCLE STRAIN 14 0.0016
511 APPENDICITIS 15 0.0016
512 OEDEMA 87 0.0016
513 PHOTOPHOBIA 30 0.0016
514 SLEEP DISORDER 112 0.0016
515 INTENTIONAL SELF-INJURY 32 0.0016
516 HYPERAESTHESIA 13 0.0016
517 DRUG EFFECT INCOMPLETE 57 0.0016
518 ANHEDONIA 41 0.0016
519 WEIGHT DECREASED 434 0.0016
520 HOT FLUSH 117 0.0016
521 SKIN WARM 9 0.0015
522 MUSCLE TIGHTNESS 25 0.0015
523 SPINAL OPERATION 19 0.0015
524 DYSGEUSIA 114 0.0015
525 THERAPEUTIC RESPONSE DECREASED 93 0.0015
526 COMA 73 0.0015
527 BEDRIDDEN 20 0.0015
528 PRODUCT DISPENSING ERROR 33 0.0015
529 PRODUCT PRESCRIBING ISSUE 33 0.0015
530 COORDINATION ABNORMAL 21 0.0015
531 DRUG DISPENSING ERROR 23 0.0015
532 UTERINE LEIOMYOMA 11 0.0015
533 ABDOMINAL DISCOMFORT 252 0.0015
534 MUSCLE SPASMS 275 0.0015
535 CONFUSIONAL STATE 242 0.0015
536 THYROID DISORDER 23 0.0015
537 ABDOMINAL PAIN UPPER 305 0.0015
538 DISCOMFORT 90 0.0015
539 CARDIAC DISORDER 138 0.0015
540 HYPERSENSITIVITY 273 0.0015
541 ILLNESS 151 0.0015
542 MEMORY IMPAIRMENT 201 0.0015
543 CHROMATURIA 33 0.0015
544 HEART RATE INCREASED 144 0.0015
545 SPINAL FRACTURE 29 0.0014
546 HYPOKINESIA 21 0.0014
547 ANAL INCONTINENCE 13 0.0014
548 ABSCESS 23 0.0014
549 PULMONARY CONGESTION 19 0.0014
550 BOWEL MOVEMENT IRREGULARITY 11 0.0014
551 OSTEOMYELITIS 26 0.0014
552 PALPITATIONS 168 0.0014
553 CHOLECYSTITIS 17 0.0014
554 INFLUENZA LIKE ILLNESS 117 0.0014
555 CANDIDA INFECTION 24 0.0014
556 CONDITION AGGRAVATED 431 0.0014
557 GASTROOESOPHAGEAL REFLUX DISEASE 114 0.0014
558 LIGAMENT SPRAIN 14 0.0014
559 JAUNDICE 38 0.0014
560 DRUG INTOLERANCE 136 0.0014
561 POST PROCEDURAL COMPLICATION 27 0.0014
562 DRUG INTERACTION 221 0.0014
563 GINGIVAL BLEEDING 19 0.0014
564 HEPATITIS ACUTE 9 0.0014
565 CARDIOMEGALY 17 0.0014
566 PRODUCT PREPARATION ISSUE 9 0.0014
567 ADVERSE DRUG REACTION 123 0.0014
568 ORAL CANDIDIASIS 18 0.0014
569 EXTRA DOSE ADMINISTERED 55 0.0014
570 FACIAL PAIN 12 0.0013
571 INCORRECT ROUTE OF DRUG ADMINISTRATION 48 0.0013
572 RESPIRATORY ARREST 37 0.0013
573 NIGHT SWEATS 43 0.0013
574 TREATMENT NONCOMPLIANCE 73 0.0013
575 HYPOAESTHESIA 199 0.0013
576 PAROSMIA 10 0.0013
577 PANCREATITIS 70 0.0013
578 EXOSTOSIS 12 0.0013
579 INSURANCE ISSUE 20 0.0013
580 FALL 435 0.0013
581 FEELING HOT 80 0.0013
582 GENERALISED OEDEMA 16 0.0013
583 MASS 18 0.0013
584 MIDDLE INSOMNIA 24 0.0013
585 PELVIC FRACTURE 10 0.0013
586 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 22 0.0013
587 CHOKING 25 0.0013
588 HEPATIC CIRRHOSIS 24 0.0013
589 PAIN IN JAW 36 0.0013
590 CHEST PAIN 234 0.0013
591 BONE PAIN 74 0.0013
592 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
593 ATRIAL FLUTTER 10 0.0013
594 DRUG TOXICITY 17 0.0012
595 PARAESTHESIA ORAL 18 0.0012
596 LIVER DISORDER 55 0.0012
597 PRODUCT ADMINISTRATION ERROR 25 0.0012
598 INJECTION SITE INDURATION 16 0.0012
599 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 87 0.0012
600 INJECTION SITE EXTRAVASATION 15 0.0012
601 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
602 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 63 0.0012
603 LOCAL SWELLING 21 0.0012
604 AMENORRHOEA 21 0.0012
605 LIVE BIRTH 10 0.0012
606 ASTHENIA 448 0.0012
607 CHOLELITHIASIS 39 0.0012
608 SWELLING FACE 77 0.0012
609 URTICARIA 197 0.0012
610 TINNITUS 54 0.0012
611 RHABDOMYOLYSIS 49 0.0012
612 PAIN IN EXTREMITY 345 0.0012
613 CARDIAC MURMUR 10 0.0012
614 SWELLING 108 0.0012
615 INCREASED APPETITE 22 0.0012
616 HEART RATE IRREGULAR 26 0.0011
617 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
618 HAEMATEMESIS 29 0.0011
619 VISION BLURRED 157 0.0011
620 LIVER INJURY 28 0.0011
621 SPINAL OSTEOARTHRITIS 10 0.0011
622 MICTURITION URGENCY 13 0.0011
623 INCONTINENCE 12 0.0011
624 COGNITIVE DISORDER 53 0.0011
625 HEPATIC ENZYME INCREASED 77 0.0011
626 VITAMIN D DEFICIENCY 11 0.0011
627 DEHYDRATION 150 0.0011
628 INTENTIONAL OVERDOSE 72 0.0011
629 BODY TEMPERATURE DECREASED 11 0.0011
630 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
631 MUSCLE DISORDER 9 0.0011
632 HEART RATE DECREASED 39 0.0011
633 ABDOMINAL PAIN 258 0.0011
634 PHARYNGITIS STREPTOCOCCAL 12 0.0011
635 INABILITY TO AFFORD MEDICATION 11 0.0011
636 GASTRIC DISORDER 38 0.0011
637 SHOCK HAEMORRHAGIC 9 0.0011
638 GASTROINTESTINAL DISORDER 99 0.0011
639 ACUTE HEPATIC FAILURE 15 0.0011
640 HEPATIC FAILURE 33 0.0011
641 NERVOUS SYSTEM DISORDER 34 0.0011
642 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
643 HAEMOPTYSIS 30 0.0011
644 BLISTER 60 0.0011
645 THIRST 19 0.0011
646 PRODUCT DOSE OMISSION IN ERROR 30 0.0011
647 FRACTURE 20 0.0011
648 ADVERSE REACTION 14 0.0011
649 WEIGHT INCREASED 236 0.0011
650 PARALYSIS 15 0.0010
651 CYST 13 0.0010
652 COMPLETED SUICIDE 87 0.0010
653 BONE DISORDER 19 0.0010
654 HYSTERECTOMY 9 0.0010
655 PERIPHERAL SWELLING 159 0.0010
656 MUSCULOSKELETAL PAIN 54 0.0010
657 RENAL DISORDER 48 0.0010
658 IMPAIRED GASTRIC EMPTYING 14 0.0010
659 DIZZINESS 506 0.0010
660 URINARY INCONTINENCE 30 0.0010
661 FATIGUE 788 0.0010
662 INTESTINAL OBSTRUCTION 38 0.0010
663 HUNGER 14 0.0010
664 GASTROINTESTINAL INFECTION 9 0.0010
665 AGEUSIA 25 0.0010
666 HYPERTENSION 212 0.0010
667 GASTROINTESTINAL PAIN 11 0.0010
668 DIARRHOEA 642 0.0010
669 ARTHRITIS 78 0.0010
670 INTESTINAL PERFORATION 11 0.0010
671 ABNORMAL FAECES 8 0.0010
672 PRURITUS GENERALISED 21 0.0010
673 BURNING SENSATION 68 0.0010
674 OSTEOARTHRITIS 41 0.0010
675 DERMATITIS CONTACT 11 0.0010
676 HEPATIC ENCEPHALOPATHY 9 0.0010
677 CHOLECYSTECTOMY 11 0.0010
678 LIP SWELLING 32 0.0010
679 LYMPHADENOPATHY 34 0.0010
680 RASH PRURITIC 52 0.0010
681 BRAIN FOG 15 0.0010
682 BLOOD PRESSURE ABNORMAL 19 0.0010
683 VISUAL IMPAIRMENT 118 0.0010
684 VERTIGO 58 0.0010
685 ELECTROLYTE IMBALANCE 11 0.0009
686 DRUG ADMINISTRATION ERROR 29 0.0009
687 GAIT DISTURBANCE 179 0.0009
688 IRRITABLE BOWEL SYNDROME 20 0.0009
689 DIZZINESS POSTURAL 9 0.0009
690 DYSTONIA 18 0.0009
691 GAIT INABILITY 31 0.0009
692 APHASIA 28 0.0009
693 BLOOD IRON DECREASED 11 0.0009
694 MUSCULOSKELETAL STIFFNESS 81 0.0009
695 MENSTRUATION DELAYED 10 0.0009
696 DYSPNOEA 522 0.0009
697 PALLOR 25 0.0009
698 LUNG DISORDER 45 0.0009
699 PULMONARY THROMBOSIS 10 0.0009
700 PNEUMONIA 296 0.0009
701 ASPIRATION 10 0.0009
702 GASTRITIS 24 0.0009
703 INTENTIONAL DOSE OMISSION 26 0.0009
704 ANKYLOSING SPONDYLITIS 12 0.0009
705 BLOOD PRESSURE INCREASED 139 0.0009
706 SURGERY 53 0.0009
707 WOUND 25 0.0009
708 PRODUCT PHYSICAL ISSUE 18 0.0009
709 FISTULA 10 0.0009
710 FREQUENT BOWEL MOVEMENTS 24 0.0009
711 APPLICATION SITE IRRITATION 11 0.0009
712 MOTOR DYSFUNCTION 9 0.0009
713 BODY TEMPERATURE INCREASED 18 0.0009
714 AKATHISIA 12 0.0009
715 INITIAL INSOMNIA 9 0.0009
716 EAR PAIN 17 0.0009
717 PULMONARY MASS 13 0.0009
718 MOVEMENT DISORDER 28 0.0009
719 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
720 DIABETES MELLITUS 66 0.0009
721 FLUID RETENTION 44 0.0009
722 BLOOD POTASSIUM DECREASED 26 0.0009
723 DYSPHAGIA 82 0.0009
724 CARDIAC ARREST 71 0.0009
725 EPILEPSY 26 0.0008
726 GENERAL PHYSICAL HEALTH DETERIORATION 98 0.0008
727 ATAXIA 10 0.0008
728 GASTRIC ULCER 16 0.0008
729 MUSCULOSKELETAL DISORDER 16 0.0008
730 OXYGEN SATURATION DECREASED 47 0.0008
731 HYPOACUSIS 36 0.0008
732 IMMUNE SYSTEM DISORDER 11 0.0008
733 DECREASED ACTIVITY 9 0.0008
734 CHRONIC KIDNEY DISEASE 63 0.0008
735 PULMONARY OEDEMA 37 0.0008
736 THROAT IRRITATION 37 0.0008
737 MYALGIA 140 0.0008
738 DYSSTASIA 24 0.0008
739 PARAESTHESIA 129 0.0008
740 RASH GENERALISED 21 0.0008
741 BRADYCARDIA 43 0.0008
742 COLON CANCER 12 0.0008
743 MALNUTRITION 9 0.0008
744 PERIPHERAL COLDNESS 11 0.0008
745 PNEUMONIA ASPIRATION 20 0.0008
746 BALANCE DISORDER 69 0.0008
747 INFLUENZA 89 0.0008
748 EYE DISORDER 26 0.0008
749 TACHYCARDIA 70 0.0008
750 DRUG LEVEL INCREASED 13 0.0008
751 NEOPLASM 9 0.0008
752 TARDIVE DYSKINESIA 22 0.0008
753 EYE SWELLING 29 0.0008
754 CONTUSION 75 0.0008
755 OROPHARYNGEAL PAIN 72 0.0008
756 HIP FRACTURE 25 0.0008
757 MYOCARDIAL INFARCTION 135 0.0008
758 ENCEPHALOPATHY 19 0.0008
759 SKIN ULCER 20 0.0008
760 RASH MACULAR 27 0.0008
761 APPLICATION SITE PAIN 17 0.0008
762 SYNCOPE 77 0.0008
763 SPINAL PAIN 9 0.0008
764 NEUROPATHY PERIPHERAL 73 0.0008
765 MENORRHAGIA 15 0.0008
766 ARTHRALGIA 317 0.0008
767 SKIN DISCOLOURATION 35 0.0008
768 RASH 332 0.0008
769 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
770 MYOCLONUS 9 0.0008
771 GASTROENTERITIS 11 0.0008
772 CYSTITIS 24 0.0008
773 MUSCLE RIGIDITY 9 0.0008
774 BACTERIAL INFECTION 14 0.0007
775 POLLAKIURIA 31 0.0007
776 HEPATITIS 19 0.0007
777 HYPERGLYCAEMIA 27 0.0007
778 NO THERAPEUTIC RESPONSE 9 0.0007
779 INFLAMMATION 38 0.0007
780 RESPIRATORY DISORDER 22 0.0007
781 ASTHMA 83 0.0007
782 HEAD DISCOMFORT 13 0.0007
783 DYSPEPSIA 72 0.0007
784 DIPLOPIA 19 0.0007
785 SKIN LESION 20 0.0007
786 TENDON RUPTURE 9 0.0007
787 PHARYNGITIS 9 0.0007
788 RESPIRATORY FAILURE 52 0.0007
789 FACE OEDEMA 12 0.0007
790 LIMB DISCOMFORT 22 0.0007
791 ABDOMINAL DISTENSION 74 0.0007
792 BLOOD PRESSURE FLUCTUATION 17 0.0007
793 RENAL FAILURE 94 0.0007
794 HYPOPHAGIA 18 0.0007
795 PNEUMOTHORAX 11 0.0007
796 VAGINAL HAEMORRHAGE 30 0.0007
797 SEPSIS 77 0.0007
798 TASTE DISORDER 14 0.0007
799 NASOPHARYNGITIS 127 0.0007
800 BLINDNESS 28 0.0007
801 DYSPHONIA 40 0.0007
802 JOINT SWELLING 82 0.0007
803 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
804 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 48 0.0007
805 MALIGNANT MELANOMA 9 0.0007
806 IMPAIRED HEALING 22 0.0007
807 ANAPHYLACTIC REACTION 37 0.0007
808 HAEMORRHOIDS 13 0.0007
809 VIRAL INFECTION 22 0.0007
810 PELVIC PAIN 12 0.0007
811 BRONCHITIS 48 0.0006
812 ABASIA 16 0.0006
813 APHONIA 9 0.0006
814 HEPATIC STEATOSIS 12 0.0006
815 HERPES ZOSTER 37 0.0006
816 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
817 ACUTE KIDNEY INJURY 98 0.0006
818 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
819 EAR INFECTION 17 0.0006
820 MENSTRUATION IRREGULAR 17 0.0006
821 SINUS TACHYCARDIA 9 0.0006
822 MUSCULAR WEAKNESS 72 0.0006
823 ABDOMINAL PAIN LOWER 16 0.0006
824 SKIN DISORDER 21 0.0006
825 RASH ERYTHEMATOUS 30 0.0006
826 CHEST DISCOMFORT 64 0.0006
827 HYPOXIA 22 0.0006
828 RASH PAPULAR 14 0.0006
829 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
830 PULMONARY EMBOLISM 59 0.0006
831 SEPTIC SHOCK 27 0.0006
832 PRURITUS 237 0.0006
833 ARRHYTHMIA 29 0.0006
834 MULTIPLE FRACTURES 10 0.0006
835 OSTEOPOROSIS 25 0.0006
836 END STAGE RENAL DISEASE 11 0.0006
837 CEREBROVASCULAR ACCIDENT 102 0.0006
838 EXPIRED PRODUCT ADMINISTERED 20 0.0006
839 HYPOTHYROIDISM 19 0.0006
840 DRUG EFFECT DECREASED 32 0.0006
841 ERYTHEMA 122 0.0006
842 DEVICE FAILURE 9 0.0006
843 MOBILITY DECREASED 42 0.0006
844 FLATULENCE 33 0.0006
845 MUSCULOSKELETAL CHEST PAIN 9 0.0006
846 BLOOD URINE PRESENT 11 0.0006
847 PRODUCT USE COMPLAINT 9 0.0006
848 GLAUCOMA 11 0.0006
849 KNEE ARTHROPLASTY 12 0.0006
850 DEEP VEIN THROMBOSIS 37 0.0006
851 EYE PAIN 32 0.0006
852 PYREXIA 194 0.0006
853 DRUG DOSE OMISSION 92 0.0006
854 SINUS DISORDER 11 0.0006
855 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
856 LIVER FUNCTION TEST ABNORMAL 16 0.0005
857 OCULAR HYPERAEMIA 26 0.0005
858 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10 0.0005
859 HAEMATOCHEZIA 30 0.0005
860 ACUTE MYOCARDIAL INFARCTION 16 0.0005
861 HAEMATOMA 14 0.0005
862 PRODUCT DOSE OMISSION 35 0.0005
863 THROMBOSIS 43 0.0005
864 INFECTION 77 0.0005
865 ALOPECIA 104 0.0005
866 PULMONARY HYPERTENSION 11 0.0005
867 SHOCK 12 0.0005
868 ACUTE RESPIRATORY FAILURE 10 0.0005
869 ERUCTATION 10 0.0005
870 FEMUR FRACTURE 16 0.0005
871 INJECTION SITE MASS 19 0.0005
872 HYPERKALAEMIA 18 0.0005
873 RECTAL HAEMORRHAGE 22 0.0005
874 BLOOD PRESSURE DECREASED 34 0.0005
875 NASAL CONGESTION 30 0.0005
876 FUNGAL INFECTION 17 0.0005
877 TYPE 2 DIABETES MELLITUS 17 0.0005
878 ANAPHYLACTIC SHOCK 13 0.0005
879 DRUG INEFFECTIVE 663 0.0005
880 COLITIS 19 0.0005
881 ACNE 38 0.0005
882 HAEMATURIA 17 0.0005
883 PRODUCT QUALITY ISSUE 67 0.0005
884 WHEEZING 29 0.0005
885 URINARY TRACT INFECTION 83 0.0005
886 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
887 EXTRAPYRAMIDAL DISORDER 12 0.0005
888 MULTIPLE SCLEROSIS 23 0.0005
889 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
890 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
891 PRODUCT COMPLAINT 12 0.0005
892 HYPOTENSION 95 0.0005
893 COLITIS ULCERATIVE 21 0.0005
894 DEMENTIA 13 0.0005
895 PRODUCT PRESCRIBING ERROR 11 0.0005
896 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
897 THERAPY INTERRUPTED 33 0.0005
898 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
899 FAECES DISCOLOURED 10 0.0005
900 DEATH 396 0.0005
901 JOINT STIFFNESS 12 0.0005
902 RED BLOOD CELL COUNT DECREASED 13 0.0005
903 PRESYNCOPE 11 0.0005
904 CARDIAC FAILURE CONGESTIVE 36 0.0004
905 EYE PRURITUS 15 0.0004
906 ILL-DEFINED DISORDER 27 0.0004
907 RENAL INJURY 13 0.0004
908 DIVERTICULITIS 12 0.0004
909 FLUSHING 44 0.0004
910 INJECTION SITE PAIN 132 0.0004
911 SINUSITIS 44 0.0004
912 PRODUCT DOSE OMISSION ISSUE 126 0.0004
913 VISUAL ACUITY REDUCED 14 0.0004
914 DEAFNESS 11 0.0004
915 PRODUCTIVE COUGH 20 0.0004
916 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
917 DIABETIC KETOACIDOSIS 10 0.0004
918 MEDICATION ERROR 23 0.0004
919 SKIN BURNING SENSATION 29 0.0004
920 PANCREATITIS ACUTE 9 0.0004
921 PERICARDIAL EFFUSION 9 0.0004
922 INJECTION SITE PRURITUS 26 0.0004
923 RHEUMATOID ARTHRITIS 44 0.0004
924 CATARACT 23 0.0004
925 ANGINA PECTORIS 11 0.0004
926 EYE IRRITATION 22 0.0004
927 NO ADVERSE EVENT 69 0.0004
928 INJECTION SITE REACTION 26 0.0004
929 ANAEMIA 72 0.0004
930 BLOOD GLUCOSE DECREASED 18 0.0004
931 HYPOKALAEMIA 17 0.0004
932 DRY EYE 18 0.0004
933 NEOPLASM MALIGNANT 24 0.0004
934 ACCIDENTAL EXPOSURE TO PRODUCT 37 0.0004
935 C-REACTIVE PROTEIN INCREASED 13 0.0004
936 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
937 COUGH 100 0.0004
938 INJECTION SITE ERYTHEMA 44 0.0004
939 HAEMOGLOBIN DECREASED 36 0.0004
940 RESPIRATORY TRACT INFECTION 9 0.0003
941 COVID-19 60 0.0003
942 LACTIC ACIDOSIS 11 0.0003
943 DISEASE RECURRENCE 16 0.0003
944 INCORRECT DOSE ADMINISTERED 76 0.0003
945 CORONARY ARTERY DISEASE 10 0.0003
946 PSORIASIS 43 0.0003
947 INJECTION SITE RASH 10 0.0003
948 BLOOD CHOLESTEROL INCREASED 15 0.0003
949 MULTIPLE SCLEROSIS RELAPSE 22 0.0003
950 EPISTAXIS 24 0.0003
951 ANGIOEDEMA 14 0.0003
952 CARDIO-RESPIRATORY ARREST 13 0.0003
953 PRODUCT ADHESION ISSUE 11 0.0003
954 CEREBRAL HAEMORRHAGE 11 0.0003
955 ASCITES 9 0.0003
956 APPLICATION SITE ERYTHEMA 8 0.0003
957 OSTEONECROSIS 10 0.0003
958 TREATMENT FAILURE 25 0.0003
959 CARDIAC FAILURE 24 0.0003
960 BLOOD CREATININE INCREASED 19 0.0003
961 HYPOGLYCAEMIA 14 0.0003
962 HAEMORRHAGE 30 0.0003
963 RENAL FAILURE ACUTE 12 0.0003
964 INJECTION SITE SWELLING 21 0.0003
965 SKIN EXFOLIATION 23 0.0003
966 PSORIATIC ARTHROPATHY 11 0.0003
967 BREAST CANCER 25 0.0003
968 THERAPY NON-RESPONDER 12 0.0003
969 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
970 DYSPNOEA EXERTIONAL 10 0.0003
971 LEUKOPENIA 13 0.0003
972 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
973 RENAL IMPAIRMENT 21 0.0002
974 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
975 ECZEMA 13 0.0002
976 DRY SKIN 31 0.0002
977 DEVICE DISLOCATION 10 0.0002
978 ATRIAL FIBRILLATION 22 0.0002
979 INJECTION SITE BRUISING 18 0.0002
980 PLATELET COUNT DECREASED 24 0.0002
981 DEVICE BREAKAGE 9 0.0002
982 BLOOD GLUCOSE INCREASED 40 0.0002
983 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
984 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
985 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
986 PLEURAL EFFUSION 10 0.0002
987 PROSTATE CANCER 13 0.0002
988 HYPONATRAEMIA 9 0.0002
989 PRODUCT STORAGE ERROR 12 0.0001
990 THROMBOCYTOPENIA 13 0.0001
991 NEUTROPENIA 15 0.0001